Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-hydroxypropanamide
2. 2043-43-8
3. 2-hydroxypropionamide
4. Propanamide, 2-hydroxy-
5. Lactic Acid Amide
6. Lactic Amide
7. Dl-lactamide
8. Alpha-hydroxypropionamide
9. 65144-02-7
10. .alpha.-hydroxypropionamide
11. (+/-)-lactamide
12. 2-hydroxy-propionamide
13. 4jzp7xjn3o
14. Nsc-9903
15. Nsc-61454
16. Propanamide,2-hydroxy-
17. Dl-lactic Acid Amide
18. Unii-4jzp7xjn3o
19. Mfcd00210310
20. D,l-lactamide
21. 2-hydroxypropionam
22. Nsc 9903
23. Einecs 218-049-3
24. Iminopropylene Glycol
25. Nsc 61454
26. 2-hydroxy-propanamide
27. Alpha-hydroxypropanamide
28. 2-hydroxypropanamide #
29. Dl-lactamide, 97%
30. Mech(oh)conh2
31. Lactamide, Dl-
32. Lactamide [inci]
33. Ch3ch(oh)conh2
34. Acetonedi-n-butylacetal
35. Chebi:75144
36. Dtxsid90862816
37. Nsc9903
38. Nsc61454
39. Bbl012097
40. Mfcd00008017
41. Stk045828
42. Akos000491583
43. Akos016352359
44. Sb44655
45. Sb44681
46. Sb83792
47. As-57860
48. Sy022608
49. Ft-0604664
50. Ft-0678220
51. Ft-0773142
52. L0001
53. En300-72519
54. D91225
55. Q6468911
56. Z57206008
| Molecular Weight | 89.09 g/mol |
|---|---|
| Molecular Formula | C3H7NO2 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 89.047678466 g/mol |
| Monoisotopic Mass | 89.047678466 g/mol |
| Topological Polar Surface Area | 63.3 Ų |
| Heavy Atom Count | 6 |
| Formal Charge | 0 |
| Complexity | 61.8 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Lactamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lactamide, including repackagers and relabelers. The FDA regulates Lactamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lactamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lactamide supplier is an individual or a company that provides Lactamide active pharmaceutical ingredient (API) or Lactamide finished formulations upon request. The Lactamide suppliers may include Lactamide API manufacturers, exporters, distributors and traders.
Lactamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lactamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lactamide GMP manufacturer or Lactamide GMP API supplier for your needs.
A Lactamide CoA (Certificate of Analysis) is a formal document that attests to Lactamide's compliance with Lactamide specifications and serves as a tool for batch-level quality control.
Lactamide CoA mostly includes findings from lab analyses of a specific batch. For each Lactamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lactamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Lactamide EP), Lactamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lactamide USP).
LOOKING FOR A SUPPLIER?
